Dose escalation studies of cytarabine, daunorubicin, and etoposide with and without multidrug resistance modulation with PSC-833 in untreated adults with acute myeloid leukemia younger than 60 years: final induction results of Cancer and Leukemia Gr (Q45130073)
Jump to navigation
Jump to search
scientific article published in November 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dose escalation studies of cytarabine, daunorubicin, and etoposide with and without multidrug resistance modulation with PSC-833 in untreated adults with acute myeloid leukemia younger than 60 years: final induction results of Cancer and Leukemia Gr |
scientific article published in November 2004 |
Statements
1 reference
Dose escalation studies of cytarabine, daunorubicin, and etoposide with and without multidrug resistance modulation with PSC-833 in untreated adults with acute myeloid leukemia younger than 60 years: final induction results of Cancer and Leukemia Gr (English)
1 reference
1 reference
Cancer and Leukemia Group B
1 reference
Clara D Bloomfield
1 reference
Michael A Caligiuri
1 reference
James W Vardiman
1 reference
David D Hurd
1 reference
Jonathan E Kolitz
1 reference
Enrique Velez-Garcia
1 reference
Bayard L Powell
1 reference
Stephen L George
1 reference
Richard K Dodge
1 reference
Steven L Allen
1 reference
Joseph O Moore
1 reference
Thomas C Shea
1 reference
Eva Hoke
1 reference
1 November 2004
1 reference
1 reference
Identifiers
1 reference